These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6087780)

  • 21. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
    Crouch CF; Mackenzie A; Dimmock NJ
    J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.
    Stanton GJ; Lloyd RE; Sarzotti M; Blalock JE
    Mol Biother; 1989; 1(6):305-10. PubMed ID: 2558683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
    Barrett AD; Dimmock NJ
    J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cycloleucine on SFV A7(74) infection in mice.
    Amor S; Webb HE
    Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.
    Kraaijeveld CA; Jansen J; Benaissa-Trouw B; Snippe H
    Arch Virol; 1983; 78(1-2):115-8. PubMed ID: 6316872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro heterologous cytotoxicity by T effector cells from mice immunized with Sindbis virus.
    Peck R; Brown A; Wust CJ
    J Immunol; 1979 Oct; 123(4):1763-6. PubMed ID: 314471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes.
    Morris A; Tomkins PT; Maudsley DJ; Blackman M
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():99-106. PubMed ID: 3492589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal enzyme changes in macrophages from mice given myocrisin and infected with avirulent Semliki Forest virus.
    Mehta S; Webb HE
    Br J Exp Pathol; 1982 Aug; 63(4):443-6. PubMed ID: 6295431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic macrophages: a rapid nonspecific response to viral infection.
    Rodda SJ; White DO
    J Immunol; 1976 Dec; 117(6):2067-72. PubMed ID: 1086869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Ekstijn GL; Kraaijeveld CA; Snippe H
    Immunology; 1992 Feb; 75(2):224-31. PubMed ID: 1551685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
    Gates MC; Sheahan BJ; Atkins GJ
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():73-80. PubMed ID: 6319575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a T-cell related factor as the cause of demyelination in mice following Semliki Forest virus infection.
    Jenkins HG; Tansey EM; Macefield F; Ikeda H
    Brain Res; 1988 Aug; 459(1):145-7. PubMed ID: 2458803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
    Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
    Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG subclass responses in brain and serum in Semliki Forest virus demyelinating encephalitis.
    Parsons LM; Webb HE
    Neuropathol Appl Neurobiol; 1992 Aug; 18(4):351-9. PubMed ID: 1326725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T-cell response to Ectromelia virus-infected cells. Different H-2 requirements for triggering precursor T-cell induction or lysis by effector T cells defined by the BALB/c-H-2db mutation.
    Blanden RV; McKenzie IF; Kees U; Melvold RW; Kohn HI
    J Exp Med; 1977 Sep; 146(3):869-80. PubMed ID: 70498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
    Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA
    Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of viral infection on experimental allergic encephalomyelitis in mice.
    Wu LX; Mäkelä MJ; Röyttä M; Salmi A
    J Neuroimmunol; 1988 May; 18(2):139-53. PubMed ID: 2833534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of gold sodium thiomalate and its constituent part, thiomalate, on the virus titres and the lysosomal enzyme activity in peritoneal macrophages of Swiss/A2G mice infected with the avirulent strain of Semliki Forest virus.
    Mehta S; Webb HE
    J Exp Pathol (Oxford); 1990 Jun; 71(3):359-66. PubMed ID: 2164826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.